Palliation of advanced pelvic malignant disease with large fraction pelvic radiation and misonidazole: Final report of rtog phase I/II study
- 1 October 1987
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 13 (10) , 1479-1482
- https://doi.org/10.1016/0360-3016(87)90314-2
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Misonidazole combined with large-fraction pelvic irradiation in the treatment of patients with advanced pelvic malignanciesAmerican Journal of Clinical Oncology, 1983
- Changes in early and late radiation responses with altered dose fractionation: Implications for dose-survival relationshipsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Radiation therapy oncology group clinical trials with misonidazoleCancer, 1981
- Misonidazole—A drug for trial in radiotherapy and oncologyInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Whole pelvis megavoltage irradiation with single doses of 1000 rad to palliate advanced gynecologic cancersInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Differential cytotoxic effects of metronidazole and other nitro-heterocyclic drugs against hypoxic tumour cellsInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Clinical testing of the radiosensitiser Ro-07-0582 III. Response of tumoursClinical Radiology, 1976
- Experience with Altered Fractionation in Radiation Therapy of Breast CancerRadiology, 1968